These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 34289162)

  • 21. Long covid clinics should be run as research hubs.
    McCartney M; Byng R
    BMJ; 2021 Aug; 374():n1996. PubMed ID: 34417203
    [No Abstract]   [Full Text] [Related]  

  • 22. First steps towards diagnosing long COVID.
    eBioMedicine
    EBioMedicine; 2022 Oct; 84():104306. PubMed ID: 36243455
    [No Abstract]   [Full Text] [Related]  

  • 23. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation.
    Hussain N; Agarwala P; Iqbal K; Omar HMS; Jangid G; Patel V; Rathore SS; Kumari C; Velasquez-Botero F; López GAB; Vishwakarma Y; Nipu AP; Ahmed NK
    J Med Virol; 2022 Apr; 94(4):1391-1401. PubMed ID: 34931698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection.
    Misgar RA; Rasool A; Wani AI; Bashir MI
    J Endocrinol Invest; 2021 Dec; 44(12):2855-2856. PubMed ID: 34215999
    [No Abstract]   [Full Text] [Related]  

  • 25. Post-COVID-19 Syndrome: Leveraging the Patient Perspective and Technological Innovations to Enable the Delineation of Effective Treatments.
    Roe MT; Patrick-Lake B; von Eschenbach AC
    Drugs; 2021 Jul; 81(10):1235-1237. PubMed ID: 34132992
    [No Abstract]   [Full Text] [Related]  

  • 26. Post-COVID-19 Syndrome (PC19S): Chronic Reactive Endotheliitis and Disseminated Vascular Disease.
    López Castro J
    Acta Med Port; 2020 Dec; 33(12):859. PubMed ID: 33496258
    [No Abstract]   [Full Text] [Related]  

  • 27. Long COVID has exposed medicine's blind-spot.
    Burke MJ; Del Rio C
    Lancet Infect Dis; 2021 Aug; 21(8):1062-1064. PubMed ID: 34153235
    [No Abstract]   [Full Text] [Related]  

  • 28. Could tiny blood clots cause long COVID's puzzling symptoms?
    Willyard C
    Nature; 2022 Aug; 608(7924):662-664. PubMed ID: 36002482
    [No Abstract]   [Full Text] [Related]  

  • 29. A patient infected with SARS-CoV-2 over 100 days.
    Abe T; Ikeda T; Tokuda Y; Ito J; Suzuki Y; Narahara C; Iriyama H; Sato K
    QJM; 2021 Feb; 114(1):47-49. PubMed ID: 33064816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunology and immunopathology of COVID-19.
    Merad M; Blish CA; Sallusto F; Iwasaki A
    Science; 2022 Mar; 375(6585):1122-1127. PubMed ID: 35271343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
    Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ
    Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post covid 19 pulmonary fibrosis. Is it real threat?
    Rai DK; Sharma P; Kumar R
    Indian J Tuberc; 2021 Jul; 68(3):330-333. PubMed ID: 34099197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post COVID syndrome: a new challenge for medicine.
    Tirelli U; Taibi R; Chirumbolo S
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4422-4425. PubMed ID: 34227079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulation and Regenerative Capacity of MSCs for Long-COVID.
    Loke XY; Imran SAM; Tye GJ; Wan Kamarul Zaman WS; Nordin F
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study.
    Søraas A; Kalleberg KT; Dahl JA; Søraas CL; Myklebust TÅ; Axelsen E; Lind A; Bævre-Jensen R; Jørgensen SB; Istre MS; Kjetland EF; Ursin G
    PLoS One; 2021; 16(8):e0256142. PubMed ID: 34437579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staying tuned for post-COVID-19 syndrome: looking for new research to sniff out.
    Barbato C; Di Certo MG; Gabanella F; Petrella C; Fiore M; Passananti C; Colizza A; Cavalcanti L; Ralli M; Greco A; De Vincentiis M; Minni A
    Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5318-5321. PubMed ID: 34486708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promotion of non-evidence-based therapeutics within patient-led Long COVID support groups.
    van der Togt V; Mcfarland S; Esperti M; Semper E; Citrenbaum S; Rossman JS
    Nat Med; 2021 Dec; 27(12):2068-2069. PubMed ID: 34893773
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular complications in the post-acute COVID-19 syndrome: A novel perspective down the road.
    El-Arabey AA; Abdalla M
    Travel Med Infect Dis; 2022; 49():102421. PubMed ID: 35944886
    [No Abstract]   [Full Text] [Related]  

  • 39. Asthma exacerbation associated with COVID-19 pneumonia.
    Ono Y; Obayashi S; Horio Y; Niimi K; Hayama N; Ito Y; Oguma T; Asano K
    Allergol Int; 2021 Jan; 70(1):129-130. PubMed ID: 32732153
    [No Abstract]   [Full Text] [Related]  

  • 40. Community-Based Primary Care Management of 'Long COVID': A Center of Excellence Model at NYC Health+ Hospitals.
    List JM; Long TG
    Am J Med; 2021 Oct; 134(10):1232-1235. PubMed ID: 34270990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.